Truist Financial’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Truist Financial’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,738	Closed	-$14.9K	–	2764
2024 Q1	$14.9K	Hold	20,738	–	–	﹤0.01%	2601
2023 Q4	$17.6K	Hold	20,738	–	–	﹤0.01%	2617
2023 Q3	$28.4K	Hold	20,738	–	–	﹤0.01%	2563
2023 Q2	$52.3K	Hold	20,738	–	–	﹤0.01%	2536
2023 Q1	$47.1K	Hold	20,738	–	–	﹤0.01%	2535
2022 Q4	$29K	Hold	20,738	–	–	﹤0.01%	2531
2022 Q3	$41K	Hold	20,738	–	–	﹤0.01%	2474
2022 Q2	$33K	Buy	+20,738	New	+$78.4K	﹤0.01%	2593

Other funds holding VAXX

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

CGL

Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Truist Financial's VAXX Position: Q2 2024 in Review

Truist Financial sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 20,738 shares — an estimated $14.9K sold.

Truist Financial first reported a position in VAXX in Q2 2022 and held it in 8 quarters. The position peaked at $52.3K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

Truist Financial reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
Truist Financial sold 20,738 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $14.9K.
Truist Financial first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2022 and held it in 8 quarters.
Truist Financial's Vaxxinity, Inc. Class A Common Stock position peaked at $52.3K in Q2 2023.
8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Truist Financial's 13F filing for Q2 2024, filed 21 Aug 2024.